Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Clade Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Clade Therapeutics

Clade Therapeutics

Acquired

Clade Therapeutics: Innovating cell-based medicines for cancer and other severe diseases.

HQ
Boston, MA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Clade Therapeutics, founded in Cambridge by a group of prominent academic leaders and bioentrepreneurs, focuses on developing innovative cell-based medicines for treating cancer and other severe diseases. The company's core mission is to harness the power of cell therapy to create transformative treatments that address unmet medical needs. Clade's market focus is primarily on oncology, leveraging advanced biotechnology to develop novel therapeutic solutions.

Notable affiliated individuals include leading scientists and successful entrepreneurs in the biotech industry. Clade Therapeutics has achieved significant milestones, including substantial funding and strategic partnerships, which have propelled its research and development efforts. The company's impact is underscored by its acquisition by Century Therapeutics on April 11, 2024, highlighting its contributions to advancing cell therapy technologies and its potential to revolutionize cancer treatment.

Clade Therapeutics - Similar Companies

Claradele Pharmaceuticals logo

Claradele Pharmaceuticals

claradele.com

Celsius Therapeutics logo

Celsius Therapeutics

celsiustx.com

Garuda Therapeutics logo

Garuda Therapeutics

garudatx.com

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Century Therapeutics logo

Century Therapeutics

centurytx.com

Casma Therapeutics logo

Casma Therapeutics

casmatx.com

C4 Therapeutics logo

C4 Therapeutics

c4therapeutics.com

Cedilla Therapeutics logo

Cedilla Therapeutics

Ernexa Therapeutics logo

Ernexa Therapeutics

eternatx.com

Legend Biotech logo

Legend Biotech

legendbiotech.com

Platelet BioGenesis logo

Platelet BioGenesis

Celularity logo

Celularity

celularity.com

Ascent Therapeutics logo

Ascent Therapeutics

HebeCell logo

HebeCell

hebecellcorp.com

Inceptor Bio logo

Inceptor Bio

inceptor.bio

Clade Therapeutics - Quick Facts

Who are Clade Therapeutics' competitors?

Companies similar to Clade Therapeutics include Claradele Pharmaceuticals, Celsius Therapeutics, Garuda Therapeutics and Cell BioEngines.

When was Clade Therapeutics founded?

Clade Therapeutics was founded in 2020.

Where is Clade Therapeutics' headquarters located?

Clade Therapeutics' headquarters is located in Boston, MA, US.

When was Clade Therapeutics' last funding round?

Clade Therapeutics' most recent funding round was for $87M (USD) in November 2021.

How much has Clade Therapeutics raised to-date?

As of Nov 3, 2021, Clade Therapeutics has raised a total of $87M (USD).

Clade Therapeutics - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cell Therapy
  • Therapeutics
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified